KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
+17.85%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$224M
AUM Growth
+$224M
Cap. Flow
-$4.26M
Cap. Flow %
-1.9%
Top 10 Hldgs %
99.68%
Holding
17
New
1
Increased
Reduced
3
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
$176M 78.3% 2,279,519
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$24.8M 11.03% 2,964,401
ARCT icon
3
Arcturus Therapeutics
ARCT
$462M
$11.9M 5.3% 687,000
KERX
4
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$3.08M 1.37% 200,000
TOVX icon
5
Theriva Biologics
TOVX
$3.94M
$2.39M 1.07% 1,360,000
LUMO
6
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.06M 0.92% 77,437
NWBO
7
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$1.34M 0.6% 200,300
INO icon
8
Inovio Pharmaceuticals
INO
$126M
$1.11M 0.49% 102,088 -306,264 -75% -$3.33M
ADXS
9
DELISTED
Advaxis, Inc.
ADXS
$709K 0.32% 225,000
GLMD icon
10
Galmed Pharmaceuticals
GLMD
$6.96M
$633K 0.28% 65,000
NRX
11
DELISTED
NEPHROGENEX INC COM
NRX
$301K 0.13% 50,000
PVCT
12
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$172K 0.08% +200,000 New +$172K
ADXSW
13
DELISTED
Advaxis, Inc. Warrants
ADXSW
$115K 0.05% 112,500
AKTX
14
Akari Therapeutics
AKTX
$24.8M
$78K 0.03% 14,155 -9,100 -39% -$50.1K
ECTE
15
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$62K 0.03% 27,430 -1,200 -4% -$2.71K
PRKR
16
DELISTED
Parkervision Inc
PRKR
-50,000 Closed -$240K
MACK
17
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-160,585 Closed -$809K